XW13325Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5

New Technology›Anatomical Regions›Transfusion
  • Billable / Specific Code
ICD-10-PCS XW13325
CMS Source: FY 2026 ICD-10-PCS dataset. Effective Oct 1, 2025 – Sep 30, 2026.FacebookXLinkedInPrint

XW13325 is a billable ICD-10-PCS procedure code for Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The root operation Transfusion involves putting in blood or blood products. In AHRQ's Clinical Classifications Software (CCSR), this procedure falls under Potential COVID-19 therapies.

Code Identity

ICD-10-PCS Code
XW13325
Billable Status
Yes — Valid for Submission
Code Describes
Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
Short Description
Transfuse Convalesc Plasma in Periph Vein, Perc, New Tech 5
Parent Code
XW1

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation1Transfusion
4BodyPart3Peripheral Vein
5Approach3Percutaneous
6Device/Substance/Technology2Plasma, Convalescent (Nonautologous)
7Qualifier5New Technology Group 5

Clinical Classification (CCSR)

AHRQ groups XW13325 into these clinical categories.

ADM019
Potential COVID-19 therapies
Clinical domain: Administration of Therapeutic Substances

Code History

Replaces previously assigned code(s):
  • 30233K1 — Transfuse Nonaut Frozen Plasma in Periph Vein, Perc
  • 30233L1 — Transfuse Nonaut Fresh Plasma in Periph Vein, Perc

Similar Procedure Codes

Questions About XW13325

Is XW13325 a billable code?

Yes. XW13325 is a complete seven-character ICD-10-PCS code, specific enough to report Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5 on inpatient claims from October 1, 2025 through September 30, 2026.

What do the characters in XW13325 mean?

XW13325 breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 1 is the Operation (Transfusion); the 4th character 3 is the BodyPart (Peripheral Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 2 is the Device/Substance/Technology (Plasma, Convalescent (Nonautologous)); the 7th character 5 is the Qualifier (New Technology Group 5).